{"id":"W2754153257","doi":"10.1016/j.euf.2017.08.008","title":"Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study","year":2017,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Allergan; Ferring Pharmaceuticals; Astellas Pharma Europe; Astellas Pharma US; Astellas Pharma; Medtronic; Pfizer","keywords":"Mirabegron; Solifenacin; Medicine; Overactive bladder; Urology; Internal medicine; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000404637,0.0001200592,0.0002935439,0.0001388615,0.0001715825,0.00003242396,0.0001428834,0.00002774518,0.00006430514],"category_scores_gemma":[0.0001669959,0.00007434637,0.00003868762,0.0001148466,0.0001668449,0.0001009204,0.0001381997,0.0002505578,0.00000683375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001468788,"about_ca_system_score_gemma":0.00002309994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000832007,"about_ca_topic_score_gemma":0.0004974265,"domain_scores_codex":[0.9984732,0.0006082901,0.0002142207,0.0002995488,0.0002241288,0.0001806676],"domain_scores_gemma":[0.998834,0.0003205232,0.0001821819,0.0005070608,0.0001034673,0.00005275681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001839818,0.001019649,0.986127,0.000003794368,0.00079521,0.0001280014,0.00575988,0.000007357716,0.00005039202,0.000007113907,0.00004315567,0.004218629],"study_design_scores_gemma":[0.007096018,0.002421165,0.989082,0.00001013052,0.0005952938,0.000002005228,0.0004560509,0.0001361955,0.00006378802,0.00003278657,0.00003743781,0.00006714511],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906,0.000133329,0.00001977579,0.0006518752,0.00001307667,0.0007037693,0.00001627823,0.000008295678,0.007853562],"genre_scores_gemma":[0.9996871,0.00001522683,0.00002365065,0.0000488121,0.00003006471,0.000009976538,0.00002193805,0.00001815426,0.0001451279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009087011,"threshold_uncertainty_score":0.3031757,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01798864813891451,"score_gpt":0.286416191893726,"score_spread":0.2684275437548115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}